Loading...
PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease
Alzheimer’s disease (AD) is characterized by the deposition of β-amyloid within the brain parenchyma and is accompanied by the impairment of neuronal metabolism and function, leading to extensive neuronal loss. The disease involves the perturbation of synaptic function, energy, and lipid metabolism....
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer-Verlag
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2593876/ https://ncbi.nlm.nih.gov/pubmed/18625459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2008.05.003 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|